HKBMIA’s fourth training session of the “Hong Kong Biotechnology Talent Training Program”: “Safety Evaluation Elements and Pathways in Preclinical Research of Innovative Drugs”
Time of publication：19TH August 2024     Reading times：     Typeface：【LargeMiddleSmall】
 
Previous：HKBMIA successfully organized the "Hong Kong-Shenzhen Pingshan Biopharmaceutical Industry Synergy Seminar."
Next：HKBMIA successfully hosted its fifth training session of the “Hong Kong Biotechnology Talent Training Program”: “Commercial Analysis of Biopharmaceutical Projects”